NYSE:MDC

M.D.C. Stock Forecast, Price & News

$50.72
+0.21 (+0.42 %)
(As of 07/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$49.65
$50.88
50-Day Range
$47.30
$58.37
52-Week Range
$37.74
$63.86
Volume378,806 shs
Average Volume582,355 shs
Market Capitalization$3.56 billion
P/E Ratio8.27
Dividend Yield3.17%
Beta1.44
30 days | 90 days | 365 days | Advanced Chart
Receive MDC News and Ratings via Email

Sign-up to receive the latest news and ratings for M.D.C. and its competitors with MarketBeat's FREE daily newsletter.


M.D.C. logo

About M.D.C.

M.D.C. Holdings, Inc., through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name. The company conducts its homebuilding operations in Arizona, California, Nevada, Washington, Oregon, Colorado, Utah, Virginia, Maryland, and Florida. Its financial services operations comprise originating mortgage loans primarily for homebuyers; providing insurance coverage primarily to its homebuilding subsidiaries and subcontractors for homes sold by its homebuilding subsidiaries, and for work performed in completed subdivisions; acting as a re-insurer on the claims; selling third-party personal property and casualty insurance products to homebuyers; and offering title agency services to homebuilding subsidiaries and customers in Colorado, Florida, Maryland, Nevada, and Virginia. M.D.C. Holdings, Inc. was founded in 1972 and is headquartered in Denver, Colorado.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

2.71 out of 5 stars

Construction Sector

9th out of 215 stocks

Operative Builders Industry

2nd out of 22 stocks

Analyst Opinion: 3.3Community Rank: 2.8Dividend Strength: 2.5Insider Behavior: 2.5Valuation: 2.5 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











M.D.C. (NYSE:MDC) Frequently Asked Questions

Is M.D.C. a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last year. There are currently 1 sell rating, 2 hold ratings, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" M.D.C. stock.
View analyst ratings for M.D.C.
or view top-rated stocks.

What stocks does MarketBeat like better than M.D.C.?

Wall Street analysts have given M.D.C. a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but M.D.C. wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is M.D.C.'s next earnings date?

M.D.C. is scheduled to release its next quarterly earnings announcement on Thursday, July 29th 2021.
View our earnings forecast for M.D.C.
.

How can I listen to M.D.C.'s earnings call?

M.D.C. will be holding an earnings conference call on Thursday, July 29th at 12:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 877-344-7529 with passcode "10157974".

How were M.D.C.'s earnings last quarter?

M.D.C. Holdings, Inc. (NYSE:MDC) released its quarterly earnings results on Thursday, April, 29th. The construction company reported $1.51 EPS for the quarter, beating analysts' consensus estimates of $1.37 by $0.14. The construction company earned $1.04 billion during the quarter, compared to analysts' expectations of $1.14 billion. M.D.C. had a trailing twelve-month return on equity of 21.55% and a net margin of 10.34%. The company's quarterly revenue was up 49.5% on a year-over-year basis. During the same period in the previous year, the business earned $0.52 EPS.
View M.D.C.'s earnings history
.

How has M.D.C.'s stock price been impacted by COVID-19 (Coronavirus)?

M.D.C.'s stock was trading at $33.96 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MDC stock has increased by 49.4% and is now trading at $50.72.
View which stocks have been most impacted by COVID-19
.

How often does M.D.C. pay dividends? What is the dividend yield for M.D.C.?

M.D.C. declared a quarterly dividend on Wednesday, April 28th. Investors of record on Wednesday, May 12th will be given a dividend of $0.40 per share on Wednesday, May 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.15%. The ex-dividend date is Tuesday, May 11th. This is a boost from M.D.C.'s previous quarterly dividend of $0.37.
View M.D.C.'s dividend history
.

Is M.D.C. a good dividend stock?

M.D.C. pays an annual dividend of $1.60 per share and currently has a dividend yield of 3.17%. M.D.C. does not yet have a strong track record of dividend growth. The dividend payout ratio of M.D.C. is 30.95%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, M.D.C. will have a dividend payout ratio of 17.06% next year. This indicates that M.D.C. will be able to sustain or increase its dividend.
View M.D.C.'s dividend history.

What price target have analysts set for MDC?

6 Wall Street analysts have issued 12 month price targets for M.D.C.'s shares. Their forecasts range from $61.00 to $71.00. On average, they anticipate M.D.C.'s share price to reach $65.40 in the next year. This suggests a possible upside of 28.9% from the stock's current price.
View analysts' price targets for M.D.C.
or view top-rated stocks among Wall Street analysts.

Who are M.D.C.'s key executives?

M.D.C.'s management team includes the following people:
  • Mr. Larry A. Mizel, Exec. Chairman (Age 78, Pay $5.15M)
  • Mr. David D. Mandarich, Pres, CEO & Director (Age 73, Pay $4.92M)
  • Mr. Robert Nathaniel Martin, Sr. VP, CFO & Sr. VP & Principal Accounting Officer (Age 42, Pay $1.8M)
  • Ms. Rebecca B. Givens, Sr. VP & Gen. Counsel (Age 57, Pay $1.28M)
  • Mr. Ryan Berry, Director of Corp. Fin. & Assistant Treasurer
  • Mr. Kelly Taga, Chief Information Officer & VP
  • Ms. Krista Montgomery, VP of HR
  • Mr. David Viger, Chief Operating Officer for Richmond American Homes
  • Mr. Jack Gallagher, Regional Pres of Maryland, Virginia & Florida - Richmond American Homes Corp.
  • Mr. Anthony G. Berris, Pres of Financial Services

Who are some of M.D.C.'s key competitors?

What other stocks do shareholders of M.D.C. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other M.D.C. investors own include Alibaba Group (BABA), Verizon Communications (VZ), The Procter & Gamble (PG), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), The Home Depot (HD), Johnson & Johnson (JNJ), Pfizer (PFE) and QUALCOMM (QCOM).

What is M.D.C.'s stock symbol?

M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC."

Who are M.D.C.'s major shareholders?

M.D.C.'s stock is owned by many different retail and institutional investors. Top institutional shareholders include State of Alaska Department of Revenue (0.05%), Oregon Public Employees Retirement Fund (0.03%), New England Research & Management Inc. (0.01%), Brookstone Capital Management (0.01%), Raymond James Trust N.A. (0.01%) and First Command Bank (0.00%). Company insiders that own M.D.C. stock include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Jean-Frederic Viret, Larry A Mizel, Leslie B Fox, Michael A Berman, Paris G Reece III, Raymond T Baker, Robert Nathaniel Martin and Staci M Woolsey.
View institutional ownership trends for M.D.C.
.

Which institutional investors are selling M.D.C. stock?

MDC stock was sold by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund. Company insiders that have sold M.D.C. company stock in the last year include David D Mandarich, David Siegel, Herbert T Buchwald, Larry A Mizel, Leslie B Fox, Michael A Berman, Paris G Reece III, Robert Nathaniel Martin, and Staci M Woolsey.
View insider buying and selling activity for M.D.C.
or view top insider-selling stocks.

Which institutional investors are buying M.D.C. stock?

MDC stock was purchased by a variety of institutional investors in the last quarter, including New England Research & Management Inc., Brookstone Capital Management, State of Alaska Department of Revenue, First Command Bank, Raymond James Trust N.A., and Harel Insurance Investments & Financial Services Ltd..
View insider buying and selling activity for M.D.C.
or or view top insider-buying stocks.

How do I buy shares of M.D.C.?

Shares of MDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is M.D.C.'s stock price today?

One share of MDC stock can currently be purchased for approximately $50.72.

How much money does M.D.C. make?

M.D.C. has a market capitalization of $3.56 billion and generates $3.90 billion in revenue each year. The construction company earns $367.58 million in net income (profit) each year or $5.17 on an earnings per share basis.

How many employees does M.D.C. have?

M.D.C. employs 1,773 workers across the globe.

When was M.D.C. founded?

M.D.C. was founded in 1972.

What is M.D.C.'s official website?

The official website for M.D.C. is www.mdcholdings.com.

Where are M.D.C.'s headquarters?

M.D.C. is headquartered at 4350 S MONACO STREET SUITE 500, DENVER CO, 80237.

How can I contact M.D.C.?

M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The construction company can be reached via phone at 303-773-1100 or via email at [email protected]


This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.